4D Molecular Therapeutics Inc

NASDAQ:FDMT   3:59:54 PM EDT
7.61
+0.17 (+2.28%)
Earnings Announcements

4D Molecular Therapeutics Reports Full Year 2021 Financial Results

Published: 03/28/2022 20:15 GMT
4D Molecular Therapeutics Inc (FDMT) - 4d Molecular Therapeutics Reports Full Year 2021 Financial Results and Operational Highlights.
4d Molecular Therapeutics Inc - $315 Million in Cash, Cash Equivalents and Investments at End of 2021 Expected to Fund Operations Into Second Half of 2024.
Revenue is expected to be $1.09 Million
Adjusted EPS is expected to be -$0.84

Next Quarter Revenue Guidance is expected to be $1.09 Million
Next Quarter EPS Guidance is expected to be -$0.87

More details on our Analysts Page.